These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 412580)

  • 1. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy.
    Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM
    Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
    Hamminga B; Noordijk EM; van Vloten WA
    Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
    Vonderheid EC; Van Scott EJ; Wallner PE; Johnson WC
    Cancer Treat Rep; 1979 Apr; 63(4):681-9. PubMed ID: 109206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
    Kim YH; Chow S; Varghese A; Hoppe RT
    Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical mechlorethamine therapy for mycosis fungoides.
    Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
    Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of mycosis fungoides with ointment-based mechlorethamine.
    Price NM; Deneau DG; Hoppe RT
    Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
    Price NM
    Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
    Vonderheid EC
    Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
    Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
    Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total skin electron beam therapy in mycosis fungoides.
    Meyler TS; Blumberg AL; Purser P
    Cancer; 1978 Sep; 42(3):1171-6. PubMed ID: 100206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron-beam therapy for mycosis fungoides: the Stanford University experience.
    Hoppe RT; Cox RS; Fuks Z; Price NM; Bagshaw MA; Farber EM
    Cancer Treat Rep; 1979 Apr; 63(4):691-700. PubMed ID: 109207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides.
    Abel EA; Sendagorta E; Hoppe RT
    J Am Acad Dermatol; 1986 Jun; 14(6):1029-38. PubMed ID: 3722479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical mechlorethamine therapy for early stage mycosis fungoides.
    Ramsay DL; Halperin PS; Zeleniuch-Jacquotte A
    J Am Acad Dermatol; 1988 Oct; 19(4):684-91. PubMed ID: 3183094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.